# Efficiency, Safety and Portability of Neovasculgen

Study · id `cardio:ct-nct03068585` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03068585](<https://clinicaltrials.gov/study/NCT03068585>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03068585

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03068585. Randomized; no masking; primary purpose treatment. Start 2010-02 (actual); primary completion 2011-06-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03068585, source copy `cardio:ctgov-nct03068585-2017-03-03`, retrieved 2026-10-31)
- Started: 2010-02 (actual) (ClinicalTrials.gov record NCT03068585, source copy `cardio:ctgov-nct03068585-2017-03-03`, retrieved 2026-10-31)
- Primary completion: 2011-06-01 (actual) (ClinicalTrials.gov record NCT03068585, source copy `cardio:ctgov-nct03068585-2017-03-03`, retrieved 2026-10-31)
- Completion: 2011-07-01 (actual) (ClinicalTrials.gov record NCT03068585, source copy `cardio:ctgov-nct03068585-2017-03-03`, retrieved 2026-10-31)
- Countries: Russia (ClinicalTrials.gov record NCT03068585, source copy `cardio:ctgov-nct03068585-2017-03-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03068585-2017-03-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficiency, Safety and Portability of Neovasculgen
- Acronym: Neovasculgen
- Condition: Peripheral Arterial Disease
- Intervention (Drug): Neovasculgen (Cambiogeneplasmid)
- Lead sponsor: Artgen Biotech
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia (`cardio:pubmed-25770117`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication (`cardio:pubmed-29996720`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 93d19d511b8ced8002a3fdda5172ac67e47ff3fa7044849e869681fd6c28a651
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
